Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Pluristyx announced it raised $9.76 Million in an initial filing from an offering of $14.8 Million
PRIVATEJul 13, 2026•about 1 month ago
Amount Raised
$9.76 Million
Round Type
Venture - Series Unknown
SeattleBiotechnology
Company Information
Company
Pluristyx
Location
Seattle, Washington, United States
About
Pluristyx is a pioneering company at the forefront of stem cell technologies. With a mission to revolutionize the field of regenerative medicine, Pluristyx develops innovative solutions that empower breakthroughs in stem cell therapies. The company's proprietary platform, panCELLa, represents a transformative leap in stem cell research, offering enhanced freedom to operate and unparalleled potential for medical advancements at a significantly accelerated timeline. Operating from two cutting-edge North American sites, Pluristyx is dedicated to driving progress and innovation in the realm of stem cell therapies.
Don't miss Pluristyx's next move
Get an email the moment Pluristyx raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contactsJason, Chief Operating Officer and Co-Founder